Prot #GO44145: A Phase III, Multicenter, Randomized, Open-Label Study Comparing The Efficacy and Safety of Glofitamab (RO7082859) in Combination with Polatuzumab Vedotin Plus Rituximab, Cyclophospamide, Doxorubicin, and Prednisone (POLA-R-CHP) Versus POLA

Project: Research project

Project Details

StatusActive
Effective start/end date7/18/24 → 5/31/29

Funding

  • Genentech, Inc (Prot #GO44145)